|
TYPE OF LISTING
|
NEW BRUNSWICK COVERAGE
|
|
Bisphosphonates
|
Etidronate
|
Didronel; Generics Available
|
Not in Drug Formulary
|
|
Alendronate
|
Fosamax; Generics Available
|
Regular Benefit (10mg, 70mg);
Non-Benefit (5mg)
|
|
Fosavance; Generics Available
|
Regular Benefit (70 mg/5600 IU);
Non-Benefit (70 mg/2800 IU)
|
|
Risedronate
|
Actonel; Generics Available
|
Regular Benefit(5mg Generics, All 35mg);
Limited Coverage (30mg Generics);
Non-Benefit (All 150mg)
|
|
Actonel; DR
|
Non-Benefit
|
|
Zoledronic Acid
|
Aclasta; Generics Available
|
Regular Benefit (5mg inj);
Non-Benefit (4mg inj)
|
|
SERMs
|
Raloxifene
|
Evista; Generics Available
|
Regular Benefit
|
|
Teriparatide (PTH)
|
Forteo; Generics Available
|
Non-Benefit
|
|
Osnuvo (biosimilar)
|
Non-Benefit
|
|
Denosumab
|
Prolia
|
Limited Coverage
|
|
Jubbonti (biosimilar)
|
Limited Coverage
|
|
Romosozumab
|
Evenity
|
Limited Coverage
|
